People who drink coffee are less likely to develop primary late onset blepharospasm.
People who drink coffee are less likely to develop primary late onset blepharospasm (BSP), according to a report published online ahead of print by the Journal of Neurology, Neurosurgery and Psychiatry.
Giovanni Defazio from the University of Bari, Italy and co-workers, investigated the effects of coffee and smoking in 166 patients with primary late onset BSP, 228 hospital control patients with primary hemifacial spasm and 187 population control subjects.
Unadjusted logistic regression analysis demonstrated a significant inverse association of prior coffee drinking and smoking with case status for the control groups. After adjusting for age, sex, disease duration, referral centre, years of schooling and coffee drinking/cigarette smoking, the smoking estimate lacked significance, whereas the association with coffee intake and BSP did not. The strength of the inverse association between BSP and coffee intake, tended to increase with the average number of cups drunk per day and there was a significant correlation between age of BSP onset and the number of cups per day, whereas no correlation was discovered with the number of packs of cigarettes per day.
It was concluded that coffee drinking may be inversely associated with the development of primary BSP and that this association may depend, in part, on the amount of coffee consumed.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.